Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal rhGDF-5 for Early Stage Lumbar Disc Degeneration
NCT00813813Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2008
- Primary completion
- Jun 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of gdf5 in degenerative disc disease (DDD), sponsored by Johnson & Johnson. Started Jun 2008; status: completed.
02
Drugs
gdf5
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT00813813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813813.